Concepedia
Statistics
Publications
9
Citations
776
H-Index
Active since
2007
Affiliations
University of Basel(Current)
Glenmark Pharmaceuticals (Switzerland)
Glenmark Pharmaceuticals (India)
Novartis (Switzerland)
Paul Wassmann is an author at University of Basel specializing in life sciences, molecular biology, and biochemistry.
Publications per year
2007–2023
Structure of BeF3−-Modified Response Regulator PleD: Implications for Diguanylate Cyclase Activation, Catalysis, and Feedback Inhibition
Paul Wassmann, Carmen K. M. Chan, Ralf Paul et al. · Structure · 2007 · 226 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +13
Activation of the Diguanylate Cyclase PleD by Phosphorylation-mediated Dimerization
Ralf Paul, Sören Abel, Paul Wassmann et al. · Journal of Biological Chemistry · 2007 · 201 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +12
Regulatory Cohesion of Cell Cycle and Cell Differentiation through Interlinked Phosphorylation and Second Messenger Networks
Sören Abel, Peter Chien, Paul Wassmann et al. · Molecular Cell · 2011 · 167 citations · Full text
Life Sciences, Cell Biology, Molecular Biology +17
Immunoglobulin domain interface exchange as a platform technology for the generation of Fc heterodimers and bispecific antibodies
Darko Skegro, Cian Stutz, Romain Ollier et al. · Journal of Biological Chemistry · 2017 · 48 citations · Full text
Pharmacy, Biotechnology, Immunology +17
A root cause analysis to identify the mechanistic drivers of immunogenicity against the anti-VEGF biotherapeutic brolucizumab
Jeffrey D. Kearns, Paul Wassmann, Ufuk Olgaç et al. · Science Translational Medicine · 2023 · 36 citations
Medicine, Immunology, Pharmacology +15
1–5 of 9